Viking Therapeutics
VKTX
#3495
Rank
NZ$6.42 B
Marketcap
NZ$55.58
Share price
-4.69%
Change (1 day)
9.06%
Change (1 year)

Market capitalization of Viking Therapeutics (VKTX)

Market cap: NZ$6.42 Billion

As of March 2026 Viking Therapeutics has a market cap of NZ$6.42 Billion. This makes Viking Therapeutics the world's 3495th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Viking Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$6.42 B-11.5%
2025NZ$7.25 B-10.77%
2024NZ$8.13 B176.29%
2023NZ$2.94 B159.26%
2022NZ$1.13 B115.5%
2021NZ$0.52 B-7.77%
2020NZ$0.57 B-33.75%
2019NZ$0.86 B5.39%
2018NZ$0.81 B311.55%
2017NZ$0.19 B473.74%
2016NZ$34.65 M-28.18%
2015NZ$48.24 M

End of Day market cap according to different sources

On Mar 22nd, 2026 the market cap of Viking Therapeutics was reported to be:

NZ$6.42 Billion
by Nasdaq info icon info icon
NZ$6.42 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
NZ$3.30 B-48.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$11.02 B 71.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
NZ$0.21 B-96.70%๐Ÿ‡บ๐Ÿ‡ธ USA